Altevax
Location: France, office address not availablealtevax.com
Using melanin as an adjuvant, Altevax has developed an immunotherapy that triggers a strong antigen-specific immune response of CD8+ and CD4+ T cells.
Founders and contacts
- FoundersBeing confirmed, locked
- Founder emailsBeing confirmed, locked
- LinkedInCompany page, locked
Explore
More startups in France
Are you a founder of Altevax and want your details removed? Write to us and we remove them within 72 hours.